AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead.
Source: https://www.fool.com/investing/2026/02/19/3-stocks-to-buy-an…
HUBS, RL and BLKB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 3, 2026.
At least for now, concerns about a key partner have derailed Oracle’s growth story. Figma may finally be recovering from its post-IPO slump.
7.18am: FTSE facing slow start The FTSE 100 is predicted to get off to a slow start on Wednesday, while the price of gold continues to outperform the stock market and reach new heights. On the futures market, the UK equity index has been called five points lower, after yesterday gaining almost 59 points to close at 10,207.80, within touching distance of recent record highs.
